Longeveron (LGVN) Shares Outstanding (2020 - 2026)

Longeveron's (LGVN) quarterly Shares Outstanding (Entity) came in at $6.5 million in Q2 2024, up 208.45% year-on-year from $2.1 million in Q3 2023, and up 158.99% quarter-over-quarter from $2.5 million in Q1 2024.

Longeveron (LGVN) Shares Outstanding (2020 - 2026) Analysis & Trends

Longeveron's Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $6.5 million for Q2 2024.

  • On a quarterly basis, Shares Outstanding (Entity) rose 208.45% year-over-year to $6.5 million in Q2 2024; TTM through Jun 2024 was $6.5 million, a 208.45% increase from a year earlier, with the FY2023 full-year figure at $2.2 million, up 3.65% from the prior year.
  • Shares Outstanding (Entity) rose to $6.5 million in Q2 2024 per LGVN's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $6.5 million in Q2 2024 and bottomed at $1.6 million in Q2 2020.
  • The 5-year median for Shares Outstanding (Entity) is $2.1 million (2022), against an average of $2.3 million.
  • Across the five-year window, Shares Outstanding (Entity) rose 0.59% in 2023 and surged 208.45% in 2024, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $1.6 million in 2020, then rose by 18.05% to $1.9 million in 2021, then climbed by 10.86% to $2.1 million in 2022, then gained by 3.65% to $2.2 million in 2023, then surged by 199.51% to $6.5 million in 2024.
  • Per Business Quant, the three latest LGVN Shares Outstanding (Entity) figures stand at $6.5 million (Q2 2024), $2.5 million (Q1 2024), and $2.2 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 24.79 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.79 Bn
Dec 31, 2025 17.58 Bn
Sep 30, 2025 18.37 Bn
Jun 30, 2025 15.01 Bn
Mar 31, 2025 14.95 Bn
Dec 31, 2024 9.41 Bn
Sep 30, 2024 13.63 Bn
Jun 30, 2024 6.51 Mn
Mar 31, 2024 2.51 Mn
Dec 31, 2023 2.17 Mn
Sep 30, 2023 2.12 Mn
Jun 30, 2023 2.11 Mn
Mar 31, 2023 2.10 Mn
Dec 31, 2022 2.10 Mn
Sep 30, 2022 2.10 Mn
Jun 30, 2022 2.09 Mn
Mar 31, 2022 2.09 Mn
Dec 31, 2021 1.89 Mn
Sep 30, 2021 1.91 Mn
Jun 30, 2021 1.90 Mn